BrightCap Ventures
8 Jan van Goyenkade Street, Amsterdam, North Holland, 1075 HP, Netherlands
Overview
BrightCap Ventures is an early-stage VC fund based in Sofia. We invest in inspiring global founders who leverage local engineering talent, helping them succeed with our entrepreneurial experience and extensive global network.
- Total investments
- 20
- Lead investments
- 7
- Investments · 12mo
- 4
- Active investors
- 4
Sector focus
- Financial Services
- Venture Capital
Investment portfolio
- Self Inspection
Participated · Equity · Jul 2026
Self Inspection offers an AI-powered inspection platform that guides users to capture smartphone photos of a vehicle, compares images against a large dataset of damaged vehicles, and generates detailed PDF inspection reports with labor, parts, and cost estimates. The platform can also ingest OBD2 data for deeper diagnostics. Since its 2021 founding, the company says it has completed over 1 million inspections for customers including rental fleets, automotive finance companies, auctions, marketplaces, and Stellantis’ financial services arm. Self Inspection reports that its platform has reduced customer costs by over $80 million and saved more than 300,000 operational hours. The company plans to use recent funding to build more products, expand its enterprise customer base, and enter the European market.
- Paypercut
Participated · Seed · Jun 2026
Paypercut provides a full payments stack for online merchants across Central and Eastern Europe via a single integration, combining card payments, local payment methods, and multiple Buy Now Pay Later providers. Since its EUR 2M pre-seed in July 2025 the company has expanded to serve over 200 merchants across eight CEE markets and evolved from a BNPL aggregator into a full payments platform. Key product features include multi-currency settlement, onboarding fully online in days, payment links and QR payments, and an Express Checkout launching to enable one-tap Apple Pay and Google Pay flows. Paypercut operates through licensed and regulated partners across the EEA and has submitted its own EMI application with the Central Bank of Ireland, expecting authorisation in Q4 2026. The company is also developing stablecoin-based rails for high-volume non-euro corridors (starting with EUR-to-PLN and EUR-to-RON) and has a roadmap extending into treasury, FX, payouts, and embedded financial services.
- RobosizeME
Participated · Seed · Feb 2026
RobosizeME develops a managed-service automation platform that integrates with hotel property-management, reservation, point-of-sale and financial systems to deploy 24/7 "digital workers." These automations take over high-volume tasks such as OTA commission reconciliation, payment routing, rate loading and guest-profile management, reducing errors and freeing staff for guest-facing work. One U.S. hotel chain saved more than $1 million in labor costs within a year of implementation, illustrating the product’s rapid ROI. The company’s client roster includes Design Hotels, The Dorchester Collection, GHA, Kempinski, Loews Hotels, Louvre Hotels Group and Radisson Hotel Group. RobosizeME holds ISO 27001, GDPR and PCI-DSS certifications, underscoring its commitment to security and compliance. Backed by the newly raised seed capital, the team plans to accelerate deployment and scale its impact across the $580 billion global hospitality market by embedding AI directly into existing hotel workflows.
- GlycanAge
Participated · Equity · Dec 2025
Founded in 2020 by father-and-daughter duo Prof. Gordan Lauc and Nikolina Lauc, England-based GlycanAge analyzes glycans—complex sugars that coat cells and many proteins—to read inflammation-linked signals that drive ageing. Its flagship offering is an IgG glycosylation-based “inflammaging” clock that provides a detailed measure of biological age and tracks how lifestyle, environmental factors and chronic inflammation affect health over time. The company is now building indication-specific clinical tools for stress and resilience, cardiometabolic health, weight management and hormones, with plans to package these as products for practitioners. It is also validating diagnostic indications and preparing its first lab-developed tests for hospital and reference-lab use, supported by collaborations with Northwestern University Hospital and Mayo Clinic. A pilot is already live at St Catherine Specialty Hospital in Zagreb, and GlycanAge intends to roll out to more than 10 hospitals across Europe and the Middle East within a year. In Saudi Arabia, a partnership with the King Abdulaziz City for Science and Technology will host the firm’s first local laboratory to serve regional hospital networks. The company has raised at least €11.3 million to date, including a €3.9 million seed round in 2024 and the latest €7.4 million financing.
- WiseBee
Led · Seed · Aug 2025
WiseBee offers an Agentic cyber risk mitigation platform that unifies threat intelligence, risk and attack-surface monitoring and automates AI-driven remediation workflows for mid-sized, regulated companies. The platform uses autonomous security agents to detect and resolve threats around the clock, aiming to reduce time-to-response from days to hours without adding headcount. The company is working with lead customers including a local US government and top fintech, banking, and space tech institutions across Europe, and runs pilot programs with CISOs in fintech, banking, government, defense, and telecom. Founders Stoyan Stoyanov (CEO) and Taha Kazi (CDO) lead a globally distributed team with deep cybersecurity and AI/ML expertise. WiseBee is expanding across Europe and North America with early traction in CEE, the UK, DACH, and the US West Coast. With recent funding, the company plans to strengthen autonomous capabilities, broaden integrations, grow its team, and lay the groundwork for its next funding round.